Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood1996;88:3698.
2.
Corral J., González-Conejero R., Lozano ML, et al. The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol1997;99:304.
3.
Vargas M., Soto I., Pinto CR, et al. The prothrombin 20210 A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagul Fibrinolysis1999;10:39.
4.
Eikelboom JW , Baker RI, Parsons R., et al. No association between the 20210G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost1998;80:878.
5.
Croft SA, Daly ME, Steeds RP, et al. The prothrombin 20210 A allele and its association with myocardial infarction. Thromb Haemost1999;81:861.
6.
Watzke HH, Schüttrumpf J., Graf S., et al. Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res1997;87:521.
7.
Rosendaal FR , Siscovick DS, Schwartz SM, et al. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood1997;90:1747.
8.
Arruda VR, Siquiera LH, Chiaparini LC, et al. Prevalence of the prothrombin gene variant 20210G/A among patients with myocardial infarction. Cardiovasc Res1998;37:42.
9.
Doggen Cjm, Manger Cats V., Bertina RM, et al. Interaction of coagulation defects and cardiovascular risk factors. Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210 A. Circulation1998;97:1037.
10.
Rosendaal FR , Doggen Cjm, Zivelin A., et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost1998;79:706.